BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2267738)

  • 1. [Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes].
    Scudla V; Jarosová M; Kapustová M; Indrák K
    Vnitr Lek; 1990 Nov; 36(11):1081-91. PubMed ID: 2267738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients].
    Jarosová M; Scudla V; Indrák K; Kapustová M
    Vnitr Lek; 1990 Nov; 36(11):1072-80. PubMed ID: 2267737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
    Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosome anomalies in Venezuelan patients with multiple myeloma].
    Quintero M; Rojas-Atencio A; Ruiz A; González M; Herrera J; Atencio F; Delgado W; Urdaneta K; Pérez F
    Invest Clin; 2003 Dec; 44(4):327-35. PubMed ID: 14727386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
    Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
    Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
    Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
    Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
    Kuglík P; Filková H; Oltová A; Hájek R
    Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
    Schilling G; Dierlamm J; Hossfeld DK
    Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
    Sagaster V; Kaufmann H; Odelga V; Ackermann J; Gisslinger H; Rabitsch W; Zojer N; Ludwig H; Nösslinger T; Zielinski C; Drach J
    Eur J Haematol; 2007 Mar; 78(3):227-34. PubMed ID: 17253972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
    Deng SH; Xu Y; Wang YF; Mai YJ; Liu XP; Zhao YZ; Zou DH; Wang Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1685-8. PubMed ID: 17825148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
    Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G
    Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple myeloma developing myelodysplastic syndrome with thrombocytosis].
    Nakayama M; Kobayashi Y; Oshima Y; Uemura N; Shindo E; Tajika K; Yanagisawa K; Takahashi S; Irie S; Tojo A
    Rinsho Ketsueki; 1995 Jul; 36(7):703-6. PubMed ID: 7563601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
    Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
    Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic findings in patients with primary myelodysplastic syndrome and their prognostic significance. (Analysis of results in 65 patients)].
    Indrák K; Jarosová M; Sulovská I; Scudla V; Hubácek J; Sousková I; Bĕhal K; Svobodová M
    Vnitr Lek; 1994 Sep; 40(9):577-85. PubMed ID: 7975361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic study of multiple myeloma].
    Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.